Essential medicines and health products

Ebola research and development landscape of clinical candidates and trials

Public report October, 2015

Publication details

Number of pages: 34
Publication date: October 2015
Languages: English


Transparency and timely results sharing in clinical trials are extremely important to generate reliable evidence. They are even more crucial when testing is carried out in emergency settings.

A report published today presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.

Commissioned by the Bill and Melinda Gates Foundation and the US Foundation for the National Institutes for Health, with support from Wellcome Trust and the WHO, the Ebola R&D landscape of clinical candidates and trials aims to contribute to greater transparency in medical research.

“This landscape is a useful contribution to the need for transparency and results sharing in clinical R&D so that science and patients can truly benefit,” says Marie-Paule Kieny, WHO Assistant Director General.

For updates and feedback, please email: